1α,25-dihydroxy-2β-(3-hydroxypropoxy)vitamin D3 (ED-71) does not disturb fracture healing process in rat's femoral fracture model.

被引：0
|
作者：
Mori, S [1 ]
Cao, Y [1 ]
Miyamoto, K [1 ]
Iwata, K [1 ]
Mahiba, T [1 ]
Akiyama, T [1 ]
Komatsubara, S [1 ]
Manabe, T [1 ]
Norimatsu, H [1 ]
机构：
[1] Kagawa Univ, Fac Med, Kagawa, Japan
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2004年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S323 / S323
页数：1
相关论文
共 42 条
  • [31] EFFECTS OF 2 NEW VITAMIN-D3 DERIVATIVES, 22-OXA-1-ALPHA-25-DIHYDROXYVITAMIN-D3 (OCT) AND 2-BETA-(3-HYDROXYPROPOXY)-1-ALPHA,25-DIHYDROXYVITAMIN-D3 (ED-71), ON BONE METABOLISM IN ORGAN-CULTURE
    SATO, K
    NISHII, Y
    WOODIEL, FN
    RAISZ, LG
    BONE, 1993, 14 (01) : 47 - 51
  • [32] Effect of 1,25-dihydroxy vitamin D3 on fracture healing and bone remodeling in ovariectomized rat femora
    Fu, Lingjie
    Tang, Tingting
    Miao, Yanying
    Hao, Yongqiang
    Dai, Kerong
    BONE, 2009, 44 (05) : 893 - 898
  • [33] 1-ALPHA,25-DIHYDROXY-2-BETA-(3-HYDRODXYPROPOXY)VITAMIN-D3 (ED-71) CAN ACCELERATE THE HEALING-PROCESSES IN THE RABBIT LEG LENGTHENING MODEL
    HIGUCHI, Y
    TANAKA, M
    TAKEDA, S
    UCHIYAMA, Y
    YAMAMOTO, S
    KISHIMOTO, H
    YAMAMOTO, K
    SATO, K
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S290 - S290
  • [34] The Vitamin D Analog 1α,25-Dihydroxy-2β-(3-Hydroxypropyloxy) Vitamin D3 (Eldecalcitol) is a Potent Regulator of Calcium and Phosphate Metabolism
    Alex J. Brown
    Cynthia S. Ritter
    Calcified Tissue International, 2011, 89 : 372 - 378
  • [35] The Vitamin D Analog 1α,25-Dihydroxy-2β-(3-Hydroxypropyloxy) Vitamin D3 (Eldecalcitol) is a Potent Regulator of Calcium and Phosphate Metabolism
    Brown, Alex J.
    Ritter, Cynthia S.
    CALCIFIED TISSUE INTERNATIONAL, 2011, 89 (05) : 372 - 378
  • [36] A NOVEL SYNTHETIC VITAMIN-D ANALOG, 2-BETA-(3-HYDROXYPROPOXY)1-ALPHA,25-DIHYDROXYVITAMIN D-3 (ED-71), INCREASES BONE MASS BY STIMULATING THE BONE-FORMATION IN NORMAL AND OVARIECTOMIZED RATS
    TSURUKAMI, H
    NAKAMURA, T
    SUZUKI, K
    SATO, K
    HIGUCHI, Y
    NISHII, Y
    CALCIFIED TISSUE INTERNATIONAL, 1994, 54 (02) : 142 - 149
  • [37] 2α-(3-hydroxypropyl)- and 2α-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D3 accessible to vitamin D receptor mutant related to hereditary vitamin D-resistant rickets
    Kittaka, A
    Kurihara, M
    Peleg, S
    Suhara, Y
    Takayama, H
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2003, 51 (03) : 357 - 358
  • [38] REGULATORY ACTIVITIES OF 2-BETA-(3-HYDROXYPROPOXY)-1-ALPHA,25-DIHYDROXY-VITAMIN-D3, A NOVEL SYNTHETIC VITAMIN-D3 DERIVATIVE, ON CALCIUM-METABOLISM
    OKANO, T
    TSUGAWA, N
    MASUDA, S
    TAKEUCHI, A
    KOBAYASHI, T
    TAKITA, Y
    NISHII, Y
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 163 (03) : 1444 - 1449
  • [39] Acceleration of bone formation by a new vitamin D analogue, ED-71:: A comparative study with 1,25D3 on rabbit leg lengthening model.
    Tanaka, M
    Higuchi, Y
    Kake, T
    Uchiyama, Y
    Yamane, K
    Yamamoto, S
    Kishimoto, H
    Yamamoto, K
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S555 - S555
  • [40] Long-Term Treatment with Eldecalcitol (1α, 25-Dihydroxy-2β- (3-hydroxypropyloxy) Vitamin D3) Suppresses Bone Turnover and Leads to Prevention of Bone Loss and Bone Fragility in Ovariectomized Rats
    Takeda, Satoshi
    Smith, Susan Y.
    Tamura, Tatsuya
    Saito, Hitoshi
    Takahashi, Fumiaki
    Samadfam, Rana
    Haile, Solomon
    Doyle, Nancy
    Endo, Koichi
    CALCIFIED TISSUE INTERNATIONAL, 2015, 96 (01) : 45 - 55
12345